Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in Thrombo-prophylaxis

Journal of Association of Physicians of India

Volumn 61, Issue DEC, 2013, Pages 882-886

  Ishi, Sandeep V ^c   Lakshmi, M ^c   Kakde, Shailesh T ^c   Sabnis, Kirti C ^c   Jagannati, Manjeera ^c   Girish, T S ^c   Jeyaseelan, L ^b   Cherian, A M ^a  

^a Bangalore Baptist Hospital   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; LUNG EMBOLISM; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; DOUBLE-BLIND METHOD; ENOXAPARIN; FEMALE; HEPARIN; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 84889801613     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994;308:235-246
2. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-815
3. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 1991;151:933-938
4. Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest 2000;118:1680-1684
5. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004;93:259-262
6. Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006;332:325-329
7. Samama MM, Cohen AT, Darmon J-Y, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341:793-800
8. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomised, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004;110:874-879
9. Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalised medical patients. J Clin Pathol 1997;50:609-610
10. Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg 1991;78:849-852
11. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989;82:203-205
12. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995;108:978-981
13. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):338S-400S
14. Haas S. Venous thromboembolism in medical patients·the scope of the problem. Semin Thromb Hemost 2003;29 Suppl 1:17-21
15. Ambrosetti M, Salerno M, Zambelli M, et al. Deep vein thrombosis among patients entering cardiac rehabilitation after coronary artery bypass surgery. Chest 2004;125:191-96
16. Charles W. Francis. Prophylaxis for Thromboembolism in Hospitalized Medical Patients. N Engl J Med 2007;356:1438-44
17. R Parakh, VV Kakkar, AK Kakkar. Management of Venous Thromboembolism. JAPI 2007; 55:49-70
18. Mismetti P, Laporte-Simitsidis S, Tardy B, et al. Prevention of venous thromboembolism in internal medicine with Unfractionated or lowmolecular- weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 2000; 83:14-19
19. Clagett GP, Anderson Jr FA, Geerts W, et al. Prevention of venous thromboembolism. Chest 1998; 114(5 Suppl.)531S-560S.